Microbix Biosystems (TSE:MBX) Shares Down 3.8% After Insider Selling

Microbix Biosystems Inc. (TSE:MBX)’s share price was down 3.8% during trading on Thursday following insider selling activity. The company traded as low as C$0.49 and last traded at C$0.50. Approximately 188,134 shares were traded during mid-day trading, a decline of 36% from the average daily volume of 294,601 shares. The stock had previously closed at C$0.52.

Specifically, Director Cameron Lionel Groome sold 200,000 shares of the business’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Price Performance

The company has a market capitalization of C$67.67 million, a P/E ratio of 12.38 and a beta of 0.34. The company’s 50-day moving average price is C$0.37 and its two-hundred day moving average price is C$0.35. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.